{"id":"W2163887249","doi":"10.1002/hep.25541","title":"Sorafenib in clinical practice: Evidence-based use or abuse?","year":2011,"lang":"en","type":"letter","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Alberta Innovates; Fondation pour la Recherche Médicale","keywords":"Sorafenib; Medicine; Randomized controlled trial; Internal medicine; Dosing; Adverse effect; Oncology; Clinical trial; Clinical Practice; Confidence interval; Response Evaluation Criteria in Solid Tumors; Liver function; Hepatocellular carcinoma; Phases of clinical research","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0008721173,0.0005830065,0.001704667,0.0005116416,0.00005145,0.00003733145,0.0002713861,0.003038383,0.001668748],"category_scores_gemma":[0.003337088,0.0004413816,0.000536922,0.0003627366,0.0003123815,0.0003018363,0.00005749474,0.003311536,0.001093218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002109582,"about_ca_system_score_gemma":0.001455112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009515294,"about_ca_topic_score_gemma":0.0002244074,"domain_scores_codex":[0.9948779,0.00145732,0.001364279,0.001050074,0.0004288515,0.000821579],"domain_scores_gemma":[0.9926439,0.005212238,0.0005232688,0.001138143,0.0002823108,0.0002001737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001313068,0.000280714,0.5504407,0.0002039375,0.0001602459,0.05782149,0.000082454,5.655111e-9,9.406855e-7,0.000005693474,0.3883771,0.001313625],"study_design_scores_gemma":[0.002809766,0.00150956,0.007807088,0.0007802824,0.001289688,0.001077266,0.00001115609,0.0004709022,0.00006842099,0.00001931266,0.9837056,0.0004509856],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.2357949,0.004193037,0.00007149652,0.7544776,0.001747679,0.002406899,0.00003499575,0.0002398395,0.001033528],"genre_scores_gemma":[0.1420626,0.003000608,0.006020984,0.8419422,0.002140651,0.0003568006,0.0005226599,0.0001575237,0.003795994],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.5953285,"threshold_uncertainty_score":0.9998038,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4227379028771812,"score_gpt":0.3924627215105821,"score_spread":0.03027518136659912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}